Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis have?
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis has 447 citations in the OpenAlex counts ScholarIQ stores.
When was Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis published?
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis has 2017 year in the ScholarIQ index.
What is the open-access status of Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis?
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis has bronze oa status in the ScholarIQ index.
What is the DOI of Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis?
The DOI for Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis is on the source record.
What is the PMID of Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis?
The PMID for Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis is on the source record.
What is the OpenAlex record for Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis?
The OpenAlex for Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis is on the source record.